ifosfamide has been researched along with Cardiac Failure in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity." | 9.11 | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. ( Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T, 2005) |
| "To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity." | 5.11 | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. ( Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T, 2005) |
| "High-dose ifosfamide is associated with severe but usually reversible myocardial depression and malignant arrhythmias." | 5.07 | High-dose ifosfamide is associated with severe, reversible cardiac dysfunction. ( Bryant, G; Cunnion, RE; Ognibene, FP; Parker, MM; Quezado, ZM; Reda, D; Wilson, WH, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, S | 1 |
| Smeland, S | 1 |
| Mercuri, M | 1 |
| Bertoni, F | 1 |
| Longhi, A | 1 |
| Ruggieri, P | 1 |
| Alvegard, TA | 1 |
| Picci, P | 1 |
| Capanna, R | 1 |
| Bernini, G | 1 |
| Müller, C | 1 |
| Tienghi, A | 1 |
| Wiebe, T | 1 |
| Comandone, A | 1 |
| Böhling, T | 1 |
| Del Prever, AB | 1 |
| Brosjö, O | 1 |
| Bacci, G | 1 |
| Saeter, G | 1 |
| Quezado, ZM | 1 |
| Wilson, WH | 1 |
| Cunnion, RE | 1 |
| Parker, MM | 1 |
| Reda, D | 1 |
| Bryant, G | 1 |
| Ognibene, FP | 1 |
| Wexler, LH | 1 |
| DeLaney, TF | 1 |
| Tsokos, M | 1 |
| Avila, N | 1 |
| Steinberg, SM | 1 |
| Weaver-McClure, L | 1 |
| Jacobson, J | 1 |
| Jarosinski, P | 1 |
| Hijazi, YM | 1 |
| Balis, FM | 1 |
| Horowitz, ME | 1 |
| Franzen, D | 1 |
| Pöhler, E | 1 |
| Hilger, HH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma[NCT04890067] | 120 participants (Anticipated) | Observational | 2021-07-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for ifosfamide and Cardiac Failure
| Article | Year |
|---|---|
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2005 |
High-dose ifosfamide is associated with severe, reversible cardiac dysfunction.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bone | 1993 |
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosp | 1996 |
1 other study available for ifosfamide and Cardiac Failure
| Article | Year |
|---|---|
[Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Non | 1990 |